Heron Therapeutics reported $33.16M in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Adamas Pharmaceuticals ADMS:US 29.15M 2.51M
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
ALKERMES ALKS:US 139.19M 14.02M
Alnylam Pharmaceuticals ALNY:US $ 153.82M 1.08M
Amarin AMRN:US 107.2M 1.4M
Ani Pharmaceuticals ANIP:US $ 18.82M 1.23M
Anika Therapeutics ANIK:US $ 17.99M 186K
Arrowhead Research ARWR:US $ 17.86M 1.67M
Eisai 4523:JP 74.73B 4.69B
Emergent Biosolutions EBS:US $ 91.2M 10.3M
Endo International Ordinary Shares ENDP:US 170.93M 12.7M
Esperion Therapeutics ESPR:US $ 46.32M 14.75M
Flexion Therapeutics FLXN:US $ 27.41M 189K
GlaxoSmithKline GSK:LN 2.5B 183M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Heron Therapeutics HRTX:US $ 33.16M 8.35M
Immunogen IMGN:US $ 9.73M 481K
Insmed INSM:US $ 57.18M 5.63M
JAZZ PHA JAZZ:US 429.03M 168.52M
Ligand Pharmaceuticals LGND:US $ 14.71M 2.09M
Merk MRK:US $ 2.25B 376M
Nektar Therapeutics NKTR:US $ 29.56M 2.12M
Neurocrine Biosciences NBIX:US $ 143.2M 14.2M
Omeros OMER:US $ 21.56M 3.51M
Pacira Pharmaceuticals PCRX:US $ 50.81M 2.29M
Regeneron Pharmaceuticals REGN:US $ 414.7M 9.1M
Sangamo Biosciences SGMO:US $ 16.49M 338K
Surmodics SRDX:US $ 7.88M 22K
Teva Pharmaceutical Industries TEVA:US 832M 16M
Ultragenyx Pharmaceutical RARE:US $ 53.41M 152K
Veracyte VCYT:US $ 19.91M 639K
Vertex Pharmaceuticals VRTX:US $ 194.67M 2.59M
Zogenix ZGNX:US $ 33.88M 2.61M